山东药玻
(600529)
| 流通市值：159.86亿 | | | 总市值：159.86亿 |
| 流通股本：6.64亿 | | | 总股本：6.64亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 3,824,950,899.24 | 2,585,950,518.3 | 1,267,462,044.57 | 4,982,198,167.78 |
| 营业收入 | 3,824,950,899.24 | 2,585,950,518.3 | 1,267,462,044.57 | 4,982,198,167.78 |
| 二、营业总成本 | 2,966,963,655.72 | 1,999,640,334.24 | 1,004,324,485.1 | 4,070,167,292.14 |
| 营业成本 | 2,597,119,472.67 | 1,749,380,728.23 | 879,800,724.18 | 3,585,499,473.26 |
| 税金及附加 | 40,707,950.22 | 28,665,969.5 | 11,545,327.72 | 46,897,729.69 |
| 销售费用 | 92,248,624.66 | 61,957,528.83 | 28,851,372.97 | 147,502,154.89 |
| 管理费用 | 146,586,178.09 | 105,793,713.39 | 55,382,427.3 | 187,987,428.35 |
| 研发费用 | 115,324,642.87 | 77,647,127.24 | 39,921,990.72 | 137,948,117.32 |
| 财务费用 | -25,023,212.79 | -23,804,732.95 | -11,177,357.79 | -35,667,611.37 |
| 其中:利息费用 | 19,912.84 | 15,312.54 | 7,728.06 | 226,814.36 |
| 其中:利息收入 | 18,637,370.01 | 13,203,130.27 | 5,805,226.07 | 22,722,495.01 |
| 加:公允价值变动收益 | 19,843,946.28 | 14,217,607.7 | 7,633,983.58 | 22,828,648.12 |
| 加:投资收益 | 9,219,631.55 | 5,281,521.52 | 1,952,861.83 | 18,399,071.4 |
| 资产处置收益 | 329,075.59 | 254,780.79 | 231,940.06 | -5,726,646.98 |
| 资产减值损失(新) | -30,162,527.45 | -30,162,527.45 | - | -42,307,905.94 |
| 信用减值损失(新) | -4,125,156.64 | -3,470,832.08 | -5,537,938.1 | -11,388,837.66 |
| 其他收益 | 20,103,532.17 | 10,858,719.55 | 6,757,682.48 | 22,531,664.34 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 873,195,745.02 | 583,289,454.09 | 274,176,089.32 | 916,366,868.92 |
| 加:营业外收入 | 2,656,470.78 | 2,171,066.29 | 780,936.2 | 2,488,840.07 |
| 减:营业外支出 | 3,653,076.07 | 3,337,777.89 | 669,244.49 | 8,031,912.68 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 872,199,139.73 | 582,122,742.49 | 274,287,781.03 | 910,823,796.31 |
| 减:所得税费用 | 151,767,993.07 | 106,956,098.89 | 53,498,382.49 | 135,021,781.69 |
| 六、净利润 | 720,431,146.66 | 475,166,643.6 | 220,789,398.54 | 775,802,014.62 |
| 持续经营净利润 | 720,431,146.66 | 475,166,643.6 | 220,789,398.54 | 775,802,014.62 |
| 归属于母公司股东的净利润 | 720,431,146.66 | 475,166,643.6 | 220,789,398.54 | 775,802,014.62 |
| (一)基本每股收益 | 1.09 | 0.72 | 0.33 | 1.17 |
| (二)稀释每股收益 | 1.09 | 0.72 | 0.33 | 1.17 |
| 九、综合收益总额 | 720,431,146.66 | 475,166,643.6 | 220,789,398.54 | 775,802,014.62 |
| 归属于母公司股东的综合收益总额 | 720,431,146.66 | 475,166,643.6 | 220,789,398.54 | 775,802,014.62 |
| 公告日期 | 2024-10-29 | 2024-08-27 | 2024-04-23 | 2024-04-23 |
| 审计意见(境内) | | | | 标准无保留意见 |